Scholar Rock: More Than Just SMA Biotech With Q2 2025 Obesity Treatment Data (NASDAQ:SRRK)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…

ONS-5010 shows promise in wet AMD treatment, matching Lucentis By Investing.com

ISELIN, N.J. – Outlook Therapeutics, Inc. (NASDAQ:), a clinical-stage biopharmaceutical company with a current market capitalization…

FCPT Announces Tax Treatment of 2024 Distributions By Investing.com

MILL VALLEY, Calif.–(BUSINESS WIRE)–Four Corners Property Trust, Inc. (NYSE: NYSE:), a real estate investment trust primarily…

Recor Medical Statement on CMS National Coverage Analysis of Renal Denervation for the Treatment of Hypertension By Investing.com

Palo Alto, CA, Jan. 13, 2025 (GLOBE NEWSWIRE) — Recor Medical (TASE:), Inc. (Recor) and its…

Morgan Stanley upgrades Gilead on HIV treatment growth By Investing.com

Investing.com — Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:) to “overweight” from “equal weight,” raising its price…

Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program

SHANGHAI, Jan. 6, 2025 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a leading global biopharmaceutical company…

China approves Eli Lilly’s Alzheimer’s treatment Kisunla By Investing.com

INDIANAPOLIS – Eli Lilly and Company (NYSE: NYSE:), a pharmaceutical giant with a market capitalization of…